Open-label Study to Evaluate Nerindocianine as a Surgical Aid in Ureter Delineation During Minimally Invasive Surgery

Inclusion Criteria: * Provide written informed consent prior to the initiation of study procedures. * At least 18 years of age. * Consent to undergo minimally invasive, lower pelvic surgery. Exclusion Criteria: * Unwilling or unable to provide informed consent. * Unwilling or unable to comply with the requirements of the protocol. * Females who are pregnant, lactating, or planning a pregnancy throughout the study. * Patients administered indocyanine green (ICG) at the same time of the lower pelvic surgery. * Have known allergies to D-mannitol and/or citric acid. * Participation in another clinical trial involving a drug in the past 12 weeks. * Any other condition that, in the investigator's judgment, would potentially compromise the study compliance or the ability to evaluate safety or efficacy of the investigational product, or determined not a safe candidate for surgery based on standard of care for current medical condition.